England leads Europe with a new 5-minute cancer immunotherapy jab. The NHS introduces an injectable form of nivolumab, approved for 15 cancer types, enhancing patient convenience and optimizing healthcare resources. For more content like this, please visit: https://t.co/aarOCkIins #CancerTreatment# #Immunotherapy# #NHSInnovation# #Nivolumab#

Professor Richard Scolyer, an Australian pathologist, applied his melanoma immunotherapy research to treat his own aggressive brain cancer, glioblastoma. His innovative approach led to a remission period of nearly two years, offering hope for future treatments. Although his cancer has returned, his case has paved the way for upcoming clinical trials. For more content like this, please visit: https://t.co/IMkI8zsszz #BrainCancer# #Immunotherapy# #MedicalInnovation# #Glioblastoma# #RichardScolyer#

Virginia Tech scientists are using low-power electrical pulses to reprogram tumors instead of destroying them. The method boosts blood and lymph vessel growth making cancer more visible to the immune system and enhancing the impact of immunotherapy. For more content like this, please visit: https://t.co/2mTwTn6TA6 #CancerResearch# #HFIRE# #Immunotherapy# #MedicalInnovation# #VirginiaTech#